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Chronic neuropathic pain affects millions of individuals worldwide, is typically long-lasting, and remains poorly treated with existing
therapies. Neuropathic pain arising from peripheral nerve lesions is known to be dependent on the emergence of spontaneous and evoked
hyperexcitability in damaged nerves. Here, we report that the potassium channel subunit Kv9.1 is expressed in myelinated sensory
neurons, but is absent from small unmyelinated neurons. Kv9.1 expression was strongly and rapidly downregulated following axotomy,
with a time course that matches the development of spontaneous activity and pain hypersensitivity in animal models. Interestingly,
siRNA-mediated knock-down of Kv9.1 in naive rats led to neuropathic pain behaviors. Diminished Kv9.1 function also augmented
myelinated sensory neuron excitability, manifested as spontaneous firing, hyper-responsiveness to stimulation, and persistent after-
discharge. Intracellular recordings from ex vivo dorsal root ganglion preparations revealed that Kv9.1 knock-down was linked to lowered
firing thresholds and increased firing rates under physiologically relevant conditions of extracellular potassium accumulation during
prolonged activity. Similar neurophysiological changes were detected in animals subjected to traumatic nerve injury and provide an
explanation for neuropathic pain symptoms, including poorly understood conditions such as hyperpathia and paresthesias. In summary,
our results demonstrate that Kv9.1 dysfunction leads to spontaneous and evoked neuronal hyperexcitability in myelinated fibers,
coupled with development of neuropathic pain behaviors.
Introduction
Injuries to peripheral nerves, either traumatic or disease associ-
ated, can lead to neuropathic pain that is persistent, severe, and
refractory to treatment (O’Connor and Dworkin, 2009). Neuro-
pathic pain sufferers most often complain of spontaneous pain,
while many also report pain in response to non-noxious stimu-
lation (allodynia) or disproportionate to the stimulus strength
(hyperalgesia). Additionally, a percentage of patients experience
sensory abnormalities (paresthesias), which may acquire an un-
pleasant quality (dysesthesias) (Haanpää et al., 2011). At present,
neuropathic pain management is inadequate, with typically less
than half of patients reporting satisfactory (50% or better) pain
relief after treatment (O’Connor and Dworkin, 2009).
Several pathophysiological mechanisms have been identified that
might contribute to pain states, but there is widespread agreement
that a key driver is the emergence of spontaneous (ectopic) activity in
damaged sensory neurons (Sheen and Chung, 1993; Yoon et al.,
1996; Baron, 2009). The bulk of this activity develops within 24 h
following peripheral nerve injury and is most prominently detected
in myelinated A-fibers (Kajander and Bennett, 1992; Boucher et al.,
2000; Michaelis et al., 2000). Interestingly, precluding transmission
of these signals to the CNS via anesthetic block of myelinated affer-
ents alleviates neuropathic pain symptoms in patients (Campbell et
al., 1988; Gracely et al., 1992). Ectopic discharge can often be re-
corded from the neuroma site and axonal segments of damaged
nerves, but the majority appears to originate in the soma of sensory
neurons, which lie in the dorsal root ganglion (DRG) (Kajander and
Bennett, 1992).
Among the plethora of DRG genes regulated by peripheral
axotomy (LaCroix-Fralish et al., 2011), ion channels are attrac-
tive targets due to their prominent role in controlling neuronal
excitability. Indeed, a substantial body of work has established
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important links between sodium channel function and altered
excitability, particularly in acute and inflammatory pain states
(Khasar et al., 1998; Abdulla and Smith, 2001; Amir et al., 2006;
Cox et al., 2006). However, assessment of knock-out transgenics
for the best sodium channel candidates reveals a persistence of
neuropathic pain behavior and/or ectopic activity (Nassar et al.,
2005, 2006). Moreover, due to a focus on nociceptor-specific
pathways, the molecular determinants of ectopic excitability in
myelinated DRG neurons remain unknown.
Given the fundamental role of voltage-gated potassium (Kv)
channels in limiting neuronal excitability, we speculated that loss
of function of a Kv subunit could account for the excitability
changes seen in pain states. Supporting this hypothesis, it has
long been known that Kv blockers applied to sensory neurons
increase the frequency of spontaneous discharge or initiate activ-
ity from silent fibers (Kajander and Bennett, 1992). However, the
largely overlapping pharmacology of different Kv subunits has
made it challenging to link the altered excitability to specific Kv
members. Here, we have examined Kv9.1 (kcns1), a potassium
channel subunit we previously found to be strongly regulated by
traumatic injury (Maratou et al., 2009). We report that Kv9.1 is
selectively expressed in large sensory neurons, and that its down-
regulation by axotomy is critically involved in myelinated fiber
hyperexcitability and emergence of pain phenotypes.
Materials and Methods
Animals and experimental neuropathy. In all experiments, adult male
Wistar rats (150 –250 g) were used in accordance to UK Home Office
regulations and institutional guidelines. Experimental neuropathy was
induced by an L5 spinal nerve transection (SNT; n  20) (Bennett et al.,
2003). Briefly, rats were anesthetized via intraperitoneal injection of 0.25
mg kg 1 medetomidine/60 mg kg 1 ketamine solution, following which
the vertebral transverse processes were exposed via a small skin incision
and retraction of the paravertebral musculature. The L6 transverse pro-
cess was partially removed and the L5 spinal nerve was identified, tightly
ligated, and sectioned 1–2 mm distal to the silk ligature. Sham surgery
(n  4) was performed by exposing the L5 spinal nerve but without
deliberately damaging it.
In situ hybridization and fluorescent immunohistochemistry. In situ hy-
bridization (ISH) was performed on 4% paraformaldehyde (PFA)-fixed,
8-m-thick DRG sections using 35S end-labeled probes (PerkinElmer),
as previously described (Michael et al., 1997; Fricker et al., 2009). Probe
sequences were as follows: Kv9.1, gtcgatgaggttgagcggatggcagaagaagttg;
Kv2.1, tggaactcctgggactctccacgaagaaaccaga; and Kv2.2, tgcttgggaactcgtg
gggatagacctttggatg, complementary to bases 1030 –1063, 1954 –1987, and
2650 –2683 of kcns1 (accession number NM_053954.1), kcnb1
(accession number NM_013186.1), and kcnb2 (accession number
NM_054000.2) mRNAs, respectively. As a control, the hybridization re-
action was competed by addition of a 100-fold excess of unlabeled oligo-
nucleotide. Lack of staining in this control indicates that the probe is
directed to a target that can be saturated, and therefore labeling is likely to
be specific. Further confidence in the specificity of Kv9.1 detection was
drawn by observation of an identical distribution pattern using a second
probe (ctatgttttgctcaggcgtatggctcccatgcag) targeted to a distinct Kv9.1
mRNA region.
Immunohistochemistry (IHC) was performed using mouse anti-
3tub (Promega, 1:2000), mouse anti-Neurofilament 200 (NF200;
Sigma, 1:500), rabbit anti-gene-related peptide (CGRP; Sigma, 1:2000),
mouse anti-Kv2.1 (Neuromab, 1:1000), mouse anti-Kv2.2 (Neuromab,
1:1000), rabbit anti-Kv9.1 (Sigma, 1:500), and rabbit anti-ATF3 (Santa
Cruz Biotechnology, 1:200). Secondary antibodies were donkey anti-
mouse Alexa Fluor 488 and donkey anti-rabbit Alexa Fluor 546 (Invitro-
gen, both 1:1000). Isolectin B4 (IB4) binding was visualized using biotin-
conjugated IB4 (Sigma, 1:200) and AMCA avidin D (Vector
Laboratories, 1:400). For Kv2.2 IHC, tissue was subjected to antigen
retrieval (10 mM citric acid, pH 6.0, at 80°C for 30 min), and immuno-
reactivity signal was enhanced using the tyramide amplification method.
When combined with ISH, IHC was performed first, as described previ-
ously (Calvo et al., 2010).
For analysis, images were acquired on a fluorescence microscope
equipped with a polarized light block for epifluorescence. Image analysis
was conducted using ImageJ software by a single experimenter, blinded
to the sample identities. To determine Kv9.1 positivity, we measured the
mRNA (ISH silver grain density) or protein (fluorescence) signal for each
cell and compared it with the mean background signal of the image. A
threshold of signal greater than mean background plus two times its SD
was set, and cells with a value higher than this threshold were classified as
Kv9.1 positive.
Assessment of Kv9.1 distribution in naive L5 DRG was performed by
measuring the diameter of Kv9.1-positive or -negative neurons with a
clearly visible nucleus from 10 to 15 sections (300 cell profiles) per
animal (n  4). Following this, the percentage of Kv9.1 neuron positivity
in each size group was determined for each animal. Finally, the mean
percentage and SE across all animals was calculated. The same method
was used to calculate the allocation of Kv9.1() neurons within different
size subgroups. Kv9.1 colocalization with neuronal markers was deter-
mined by taking counts from at least 5–10 L5 DRG sections (300 cells)
per animal (n  4), after which percentages and SEs were calculated as
before. For analysis of Kv9.1 coexpression with Kv2 members, the same
field of view was identified on adjacent sections separated by 8 m.
Microscope photos were taken (6 – 8 sections/animal, n  3), individual
neurons visible in all views were identified, and counts of colocalization
were carried out. For analysis of Kv9.1 expression in DRG after periph-
eral axotomy, the intensity of ISH or IHC signal minus background was
calculated in all medium-large neurons (30 m) of at least six sections
(100 –200 cells) per animal (n  3– 4). Analysis of siRNA knockdown by
IHC was performed using the same method (siRNA, n  6; scrambled,
n  3).
Cell culture. Adult DRG neuron cultures were prepared from male
Wistar rats, as previously described (Wong et al., 2006), in chambered
glass slides (Labtek). Cultures were either fixed with 4% PFA and pro-
cessed for ISH and IHC or subjected to RNA isolation for quantitative
reverse transcription (qRT)-PCR, as described in the relevant section.
For in vitro validation of siRNA, pulmonary artery smooth muscle cells
(PASMC) were isolated and cultured as previously described (Knock et
al., 2008b). For determination of Kv9.1 knock-down efficiency, PASMC
(0.5  106 cells/well) were electroporated with 250 nM each Kv9.1 siRNA
(n  3) or control nontargeting siRNA (Dharmacon; n  6), according
to published protocols (Knock et al., 2008a). All Kv9.1 siRNAs were
designed using the Dharmacon algorithm; passenger strand sequences
were siRNA#1, cuuggaaucuguaggauca; siRNA#2, gaaaggugguacaaguguu;
and siRNA#3, guaccagucucuauuagau. Kv9.1 expression was analyzed by
qRT-PCR at 24 h after transfection, using the Kv9.1 and GAPDH primers
described below.
In vivo RNA interference. Anesthetized rats were subjected to a thoracic
laminectomy and a silastic tube was inserted subdurally to lie just rostral
to L3 DRG and externalized to deliver bolus injections (one injection per
day for 4 consecutive days). Animals were allowed to recover for 5 d
before treatment commenced. On the day of injection, siRNA was mixed
with i-Fect (Neuromics) to a final concentration of 0.2 g l 1, accord-
ing to published protocols (Luo et al., 2005). For each treatment, 10 –20
l of Kv9.1 siRNA or scrambled control mixture was injected, followed
by a 10 l saline flush. Twenty-four hours after the fourth injection
animals were killed and L5 DRGs fresh dissected for qRT-PCR analysis. A
separate set of animals were PFA perfused and DRGs retrieved for IHC.
Passenger strand sequences for Kv9.1 and scrambled control siRNAs
were cuuggaaucuguaggauca and gaggcctaatcgatatgtt, respectively (Dhar-
macon; “in vivo processing” option).
Behavioral assessment. Behavioral testing was conducted by a single
experimenter blinded to the identity of treatment. Mechanical and heat
pain thresholds were averaged from both paws, using the automatic von
Frey and Hargreaves methods, respectively, as previously described
(Marchand et al., 2009). Baseline values were taken 1 d before siRNA
treatment and pain responses were assessed 24 h post each injection
thereafter (Kv9.1, n  7; scrambled, n  6).
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qRT-PCR. Twenty-four hours after the last injection, L5 DRG from
both sides of control (n  5) or Kv9.1 siRNA-treated animals (n  7)
were dissected and pooled. Total RNA was isolated using RNeasy Mini
Kit (Qiagen) and cDNA was synthesized with Superscript II Reverse
Transcriptase (Invitrogen), according to manufacturer’s instructions. All
samples were run in duplicates and GAPDH was used as an internal
control. Primers used were Kv9.1; cggggaggagctcggagacc, acccacggccag-
gtacagca; GAPDH; ggctggggctcacctgaagg; and agcagttggtggtgcaggatgc.
For amplification, 57.5 ng cDNA was subjected to the following cycling
conditions: (1) 95°C, 10 min; (2) 95°C, 10 s; 63°C, 10 s; 72°C, 20 s (40
cycles); and (3) temperature ramp to 95°C. Amplification signal was
detected using SYBR Green (Roche) on a Rotor-Gene 3000 (Corbett) and
transcript levels were quantified using the Ct method.
In vivo electrophysiology. Recordings were performed on anesthetized
rats (1.5 g kg 1 urethane, i.p.), 24 h after a 4 d treatment with Kv9.1 (n 
4) or scrambled control (n  3) siRNA. Electrophysiological recordings
from neuropathic animals were performed in rats with a partial sciatic
nerve ligation (Bennett et al., 2003; n  3), 2– 4 weeks postinjury. For
each dataset, a fine L4/L5 dorsal root strand (10 –15 strands per animal)
was dissected from the dorsal root entry zone and mounted on the re-
cording electrode, whereas the L4/L5 spinal nerve segment distal to the
DRG was mounted on the stimulating electrode. All recordings com-
menced 5 min after acutely cutting the L4/L5 spinal nerve 10 mm distal
to the DRG to remove most peripheral input. The number of units com-
prising each strand (typically 8 –12) was deciphered by evoking activity in
the corresponding sensory axons via application of electrical stimulation
at incremental intensities (100 s stimulus at 1 Hz, up to 500 A) on the
spinal nerve. The activity on the root filament was filtered so that only
A-fiber activity was registered. Dividing the conduction distance by the
conduction time gave the conduction velocity of individual units. Fol-
lowing unit recruitment, each strand was monitored for spontaneously
active units for 60 s. After spontaneous activity (SA) assessment, the
spinal nerve was sequentially stimulated at 2, 5, 10, and 20 Hz (500 A
stimulus, 10 s for each frequency) and the evoked activity in the corre-
sponding strand was recorded for subsequent analysis. Finally, after-
discharge poststimulation was monitored for up to 60 s. Activity
incidence was calculated by dividing the total number of units showing
SA or stimulus-evoked activity (SEA) with the total units sampled in each
group (control, n  269; siRNA, n  369; injured, n  176). For calcu-
lation of firing rate during stimulation, the total number of spikes/s
during the first 2 s of stimulation was determined at each stimulation
Figure 1. Kv9.1 is selectively expressed in myelinated sensory neurons. A, Bright-field (BF; left) and polarized light (right) images from Kv9.1 ISH in lumbar DRG showing mRNA silver grains over
large (arrows), but not small (arrowheads) neurons. B, Kv9.1 cell-size distribution in rat lumbar DRG (n  4). C, A similar expression pattern was detected using a different Kv9.1 mRNA probe (left),
while control ISH reactions with excess unlabeled probe resulted in only background signal (right). D, IHC for neuronal markers combined with Kv9.1 ISH in a single lumbar DRG section. Merged
images (bottom, high power on right) illustrate Kv9.1 mRNA detection in NF200-positive neurons (arrows), while CGRP-positive (arrowheads) and IB4-positive (double arrowheads) neurons are
devoid of Kv9.1 signal. E, IHC showing Kv9.1 protein expression in large NF200(), but not small (some distinguished by IB4 staining) neurons of lumbar DRG. Scale bar, 50 m.
Table 1. Quantitative measurements of Kv9.1 mRNA expression in rat lumbar DRG
neurons of different sizes (n  4)
Cell size (diameter)
Percentage of DRG neurons  SE
Kv9.1 () cells in each class
Allocation of Kv9.1 ()
cells within different
classes
Small (	30 m) 5.6  1.4% 8.9  1.3%
Medium (30 – 40 m) 77.6  5.3% 31.2  2.2%
Large (40 m) 97.7  1.1% 59.9  2.3%
Table 2. Quantitative measurements of Kv9.1 mRNA colocalization with neuronal
markers in rat lumbar DRG (n  4)
Marker
Percentage of DRG neurons  SE
Kv9.1 () cells in each group
Allocation of Kv9.1 ()
cells within different
groups
CGRP 3.5  1.0% 4.0  1.4%
IB4 0.8  0.8% 0.5  0.4%
NF200 97.2  0.7% 93.1  1.5%
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frequency for each group. The firing rate per unit was then calculated by
dividing this value with the total number of active units in the group
(control, n  4; siRNA, n  22; injured, n  17). After-discharge was
expressed as the ratio of SEA spikes/s during the first 2 s poststimulation
to total number of SEA units.
Ex vivo intracellular recordings. Four groups of animals were used: naive,
injured (SNT), Kv9.1 siRNA-treated, and scrambled siRNA-treated. For in-
jured animals, recordings were performed at 3–5 d after axotomy; for
siRNA-treated animals, recordings were performed 24 h after the last of four
successive injections, as before. On the day of recording, the animal was
anesthetized with 25% urethane (w/v) (1.5 g kg1, i.p.), and L5/L4
DRG connected to the dorsal root and spinal nerve were dissected and
transferred to a recovery chamber, filled with constantly oxygenated
calcium-free Krebs’ solution containing the following (in mM): 124
NaCl, 26 NaHCO3, 1.3 NaH2PO4, 2 MgCl2, 2 CaCl2, 3 KCl, and 10
glucose. One hour later, the tissue was incubated for 20 min in 0.125%
collagenase (Sigma) containing F12 medium (Invitrogen) at 37°C, and
then transferred to the recording chamber. The tissue was then con-
stantly perfused with oxygenated 2 mM CaCl2 containing Krebs’ solution.
When 6 and 9 mM KCl was used in Krebs’ solution, NaCl was adjusted
accordingly to maintain the constant osmolarity (300 mOsm). The gan-
glion was pinned down with U-shaped pins on each side over dorsal root
and spinal nerve and the end of the dorsal root was subjected to stimu-
lation with a suction electrode. Sharp electrodes were pulled from boro-
silicate glass with filament (OD 1.5 mm  ID 0.86 mm; Sutter
Instrument). Pipette resistance was 25–50 M
 when filled with 3 mM
KCl. Recordings were made with an Axoclamp 2B amplifier (Molecular
Devices). Analog signals were lowpass filtered at 3 kHz and sampled at 5
kHz using a Power 1401 computer interface. After successfully impaling
a cell, the following protocol was applied: (1) obtain dorsal root
stimulation-evoked action potential (AP) at 3 mM [K ]e; (2) at 3 mM
[K ]e, a series of 100 ms current steps were injected into soma to obtain
threshold current (minimum amount of current to evoke an AP), follow-
ing which current was increased at 1 nA increments up to 6 – 8 nA; (3)
same procedure was repeated in 6 and 9 mM [K ]e. A small negative
pulse (0.5 nA, 20 ms) was used to monitor input resistance. For the
toxin experiment, we used the same protocol at 3 mM [K ]e in the
absence or presence of 100 nM stromatoxin-1 (Alomone Labs). Any re-
cordings during which input resistance changed 20% or resting mem-
brane potential became more depolarized than 45 mV were discarded
from analysis. Data were acquired and analyzed using Signal (CED).
Values are reported as mean  SE. Unless otherwise stated, the two
sample statistics were performed using Mann–Whitney U test.
Results
Kv9.1 is selectively expressed in myelinated sensory neurons
We first examined the expression of Kv9.1 transcripts in lumbar
DRG sections of naive rats, using ISH. Kv9.1-positive staining
was indicated by clusters of silver grains visible under polarized
light over cells and was present in 39.8  3.0% of all neurons (Fig.
1A). Size-frequency analysis revealed that Kv9.1 mRNA was ro-
bustly expressed in medium-large (30 m diameter, 89.7 
1.5%), but not small (	30 m diameter, 5.6  1.4%) neurons
(Fig. 1B; Table 1). Importantly, an identical distribution pattern
was detected using a separate Kv9.1 probe (Fig. 1C, left; medium-
large 88  3.3%, small 4.5  1.8%), while control reactions with
an excess of unlabeled probe produced only background signal
(Fig. 1C, right). In the total Kv9.1-positive population, most cells
were medium-large diameter (91.1  2.2%) and very few small
diameter (8.9  1.3%). To further characterize Kv9.1 expression
in DRG we used three protein markers of neuronal subpopula-
tions: NF200, which stains medium-large myelinated neurons;
CGRP, present in small peptidergic nociceptors; and IB4, ex-
pressed in small nonpeptidergic nociceptors. Combined ISH and
IHC for these markers in single sections (Fig. 1D; Table 2) showed
colocalization of Kv9.1 with NF200, but not CGRP or IB4. Quan-
titatively, we observed that 93.1  1.5% of Kv9.1-positive cells
were immunoreactive for NF200, while only 4.0  1.4% and
0.5  0.4% expressed the small cell markers CGRP and IB4,
Figure 2. Kv9.1 is coexpressed with Kv2 subunits in myelinated sensory neurons. A, Bright-field (top) and ISH overlay (bottom) images for Kv9.1/Kv2.1 (left) and Kv9.1/Kv2.2 (right) colocalization
detection on adjacent DRG sections. Arrows denote examples of the same neurons identified in both fields, expressing Kv9.1 and Kv2.1 (blue) or Kv9.1 and Kv2.2 (red) mRNAs. B, Immunohistological
double labeling of DRG neurons for Kv9.1 and Kv2.1 (left) or Kv2.2 (right) proteins. Examples of colocalization in large neurons are denoted by arrows. Scale bars: 50 m.
Table 3. Quantitative measurements of Kv9.1 mRNA colocalization with Kv2 mRNA
in rat lumbar DRG (n  3)
Subunit Percentage of DRG neurons  SE
Kv9.1 only 11.25  0.4
Kv9.1 and Kv2.1 48.6  4.6
Kv9.1 and Kv2.2 76.8  7.0
Kv9.1 and Kv2.1 and Kv2.2 36.7  7.5
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respectively. Conversely, most myelinated DRG cells, identified
by NF200 staining, expressed Kv9.1 (97.2  0.7%). In contrast,
only 3.5  1.0% and 0.8  0.6% of CGRP or IB4-positive neu-
rons, respectively, had Kv9.1 signal. Finally, to confirm our
mRNA distribution results, we examined the protein expression
using a commercial Kv9.1 antibody (Fig. 1E). In agreement with
ISH results, Kv9.1 protein was detected in 82.7  2.5% of
medium-large neurons, which also stained positive for NF200.
Importantly, there were only background levels of fluorescence in
smaller neurons, and no colocalization of Kv9.1 protein and IB4
staining was observed.
Kv9.1 colocalizes with Kv2 subunits in myelinated
sensory neurons
Since previous studies have suggested that Kv9.1 function is
linked to coassembly with Kv2.1 and Kv2.2 subunits (Salinas et
al., 1997; Stocker and Kerschensteiner, 1998), we investigated
whether Kv9.1 and Kv2 subunits are coexpressed in DRG neu-
rons. To achieve this, we performed ISH (Fig. 2A) for Kv9.1/
Kv2.1 (left) and Kv9.1/Kv2.2 (right) in adjacent DRG sections
and were able to directly observe colocalization of these mRNAs
in single medium-large neurons (arrows). Examining the Kv9.1-
positive population, we found that 48.6 and 76.9% of cells coex-
Figure 3. Kv9.1 is rapidly and robustly downregulated in DRG after nerve injury. A, Animals subjected to sham surgery retain Kv9.1 expression (i), while Kv9.1 mRNA signal is virtually absent in
L5 DRG at 14 d postaxotomy (ii). All axotomized L5 DRG neurons lacking Kv9.1 signal are stained positive for the nerve injury marker ATF3 (iii). In the adjacent L4 only a minority of neurons feature
loss of Kv9.1 and these are also immunoreactive for ATF3 (arrows in iv). B, C, Images and quantification of Kv9.1 transcriptional downregulation after SNT, illustrating a rapid attenuation of mRNA
levels in axotomized L5 DRG as soon as 1 d postinjury, with minimal expression detected as long as day 28 (mean  SEM; n  4 per time point; ***p 	 0.001 vs sham, one-way ANOVA with Tukey’s
post hoc). D, Kv9.1 protein staining is reduced 7 d postinjury in lumbar DRG neurons. E, F, Quantification of Kv9.1 protein positivity and immunoreactivity (IR), respectively, showing Kv9.1 protein
downregulation in medium-large neurons (mean  SEM; n  3– 4 per time point; **p 	 0.01, ***p 	 0.001 vs sham, one-way ANOVA with Tukey’s post hoc). Scale bars: 50 m.
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pressed Kv2.1 or Kv2.2, respectively (Table 3). The presence of
both Kv2 subunits was documented in more than a third of all
Kv9.1-positive neurons (36.7%), while only a small number did
not express any Kv2 subunit (11.25%).
To extend the Kv9.1 and Kv2 coexpression data at the protein
level, we performed double immunohistological labeling for
Kv9.1 and either Kv2.1 (Fig. 2B, left) or Kv2.2 (Fig. 2B, right)
using commercially available antibodies. This analysis confirmed
the presence of Kv2 subunits in the majority of medium-large
DRG neurons, where extensive colocalization with Kv9.1 protein
was observed (arrows). In addition, both Kv2 subunits were also
detected in many small neurons. Together, both ISH and IHC
results demonstrate that Kv9.1 is highly colocalized with Kv2
members in myelinated neurons.
Kv9.1 is rapidly and robustly downregulated after peripheral
nerve injury
To investigate Kv9.1 regulation after nerve injury we used L5 SNT
in rats, a well characterized neuropathic pain model. Although
Kv9.1 mRNA expression was normal in animals subjected to
sham surgery, Kv9.1 mRNA signal was virtually absent in axoto-
mized L5 DRG, 14 d postinjury (Fig. 3A, i,ii). Virtually all L5
neurons featuring Kv9.1 transcriptional downregulation were
positive for the nerve injury marker activating transcription
factor-3 (ATF3; Fig. 3A, iii). Examining the time course of Kv9.1
downregulation in more detail (Fig. 3B), we detected an 60%
decrease (reduced to 43.6  3.2% of sham) in Kv9.1 levels as soon
as 24 h postsurgery, and an almost complete loss of signal (re-
duced to 6.2  1.1% of sham) by 3 d (p 	 0.001), as quantified by
ISH analysis (Fig. 3C). Kv9.1 downregulation was sustained, as
mRNA transcripts remained at low levels for at least 28 d. In the
L4 DRG, Kv9.1 mRNA levels appeared unaltered in the major-
ity of neurons (96.7  5.2% of sham, p  0.1; Fig. 3C), but in
the few medium-large cells that expressed ATF3 (and were
thus apparently injured by the surgical procedure) Kv9.1 sig-
nal was lost (Fig. 3A, iv). This observation is in agreement with
reports that the nerve exposure involved in SNT can induce
small but varying degrees of nerve injury in the spared L4
(Shortland et al., 2006).
Finally, we used IHC to confirm Kv9.1 downregulation at the
protein level (Fig. 3D). As expected, the number of neurons pos-
itive for Kv9.1 protein was rapidly reduced after injury (3 d,
29.1  3.8% reduction compared with sham, p 	 0.01) and re-
mained low thereafter (7 d, 55.9  6.4%; 14 d, 57.2  5.1%; 28 d,
63.8  6.0% reductions vs sham, p 	 0.001; Fig. 3E). Similar
conclusions were drawn from quantification of Kv9.1 immunoreac-
tivity (at least 72% reduction on days 7 through 28, p 	 0.01; Fig.
3F). In summary, the observed time course of Kv9.1 downregulation
in injured neurons correlates with the emergence of A-fiber ectopic
firing and pain behaviors in this model (Liu et al., 2000).
Kv9.1 is also downregulated in dissociated DRG cultures
To establish whether DRG cultures could constitute an in vitro
system to investigate Kv9.1 function, we examined Kv9.1 expres-
sion in acutely dissociated DRG neurons. In this preparation,
neurons undergo axotomy of their central and peripheral pro-
cesses as part of the dissection process, and as a result feature
many elements of injured phenotypes, such as ATF3 expression
(Dussor et al., 2003). Cultures that were fixed after either 3 or 72 h
postplating were stained for NF200 and CGRP and subjected to
ISH. In line with our previous results, Kv9.1 could be detected in
NF200-positive neurons at 3 h; however, no mRNA was detected
after 72 h (Fig. 4A). Subsequently, Kv9.1 expression was analyzed
by qRT-PCR (Fig. 4B). The results indicated that after 72 h in
culture, Kv9.1 signal is reduced by 86.5  4.3% (p 	 0.01) com-
pared with baseline (3 h postplating), an effect comparable to
SNT-induced in vivo downregulation.
Kv9.1 knock-down elicits pain behaviors in naive animals
We next sought to determine whether Kv9.1 downregulation
precedes development of pain symptoms by experimentally in-
ducing Kv9.1 knock-down in naive DRG via RNA interference.
To achieve this, we initially tested three different siRNA oligonu-
cleotide sequences for their ability to knock-down Kv9.1 in vitro.
Since dissociated DRG neurons very rapidly lose Kv9.1 expres-
sion in culture, we assayed the siRNA sequences by electroporat-
ing rat PASMC, cells that have been reported to stably express
Kv9.1 in culture (Fantozzi et al., 2006). Analysis of Kv9.1 expres-
sion by qRT-PCR 24 h post-transfection indicated that siRNA#1
was the most effective, mediating a 85.2  1.3% mRNA knock-
down (p 	 0.01) compared with a control culture transfected
with nontargeting siRNA (Fig. 5A). To examine the effect of
Kv9.1 knock-down in vivo, siRNA#1 was then delivered daily via
indwelling intrathecal catheters to the lumbar space of adult rats
for 4 consecutive days. At the end point of treatment, L5 DRGs
were retrieved and qRT-PCR or IHC was used to quantify Kv9.1
expression levels. We observed a significant decrease in Kv9.1
mRNA levels in animals treated with the Kv9.1 siRNA (Fig. 5B),
compared with a separate group of animals receiving vehicle or a
scrambled sequence control with the same dosing regimen
(38.9  9.4% decrease vs scrambled, p 	 0.05). Consistent with
Kv9.1 mRNA knockdown, immunohistological examination of
DRG sections using Kv9.1 antisera (Fig. 5C) also revealed a 23.9%
reduction in the percentage of Kv9.1-positive myelinated neu-
rons (scrambled, 83.3  1.1; siRNA, 63.4  3.8%, p 	 0.01) as
well as a 32.7% decrease in mean Kv9.1 signal intensity (67.3 
5.2% of scrambled control, p 	 0.001).
Intriguingly, behavioral assessment showed a significant re-
duction of mechanical pain thresholds in the animals treated with
Figure 4. Kv9.1 is also downregulated in DRG culture. A, Kv9.1 ISH combined with IHC for
NF200 and CGRP in dissociated DRG culture demonstrates Kv9.1 mRNA reduction in large neu-
rons (arrows) after 72 h in culture, compared with baseline (3 h postplating). B, Quantification
of Kv9.1 mRNA in vitro expression by qRT-PCR (mean  SEM; n  3 per dataset, **p 	 0.01, t
test).
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the Kv9.1 siRNA, compared with scram-
bled control (Fig. 5D). The mechanical
hyperalgesia developed over several days
and with this dose thresholds fell by
30% at 4 d post-treatment, which was
significant compared with baseline or
control group (p 	 0.001). Interestingly,
heat sensitivity of the hindpaws was not
affected (p  0.1; Fig. 5E).
Kv9.1 knock-down triggers
A-fiber hyperexcitability
We finally asked whether Kv9.1 siRNA
treatment could replicate electrophysio-
logical changes in sensory neurons that
are known to occur in neuropathic states.
In anesthetized rats, we recorded from
centrally disconnected fine strands of the
L4/L5 dorsal roots after 4 d of treatment
with either Kv9.1 siRNA or scrambled
control siRNA (Fig. 6A). Before record-
ing, we acutely cut the L4 and L5 spinal
nerves to remove peripheral input. We
observed little SA in control animals
(1.1%), but a significantly higher number
of strands sampled after Kv9.1 knock-
down showed ectopic firing (4.9%, p 	
0.05 vs control; Fig. 6B,D). The ectopic
discharge, like that seen in neuropathic
pain models, was observed in myelinated
fibers (conduction velocity range 5–55
m/s1); was either tonic, irregular, or
bursting; and had an average rate of
11.2  3.6 spikes/s1. For comparison,
using the same setup to record spontane-
ous firing in injured animals subjected to
peripheral axotomy revealed a 7.4% SA
incidence (p 	 0.01 vs control).
When stimulating the spinal nerves of Kv9.1 siRNA-treated
animals (Fig. 6A) at A-fiber strength, we observed a form of pe-
ripheral wind-up in many units (6.1%, p 	 0.01 vs control),
including previously silent units without any apparent spon-
taneous firing. This excitability was manifested as a delayed and
frequency-dependent activation of the unit, usually with a very
prominent after-discharge, which we dubbed SEA (Fig. 6C, dou-
ble arrowheads). In contrast, SEA was very rarely detected in
scrambled siRNA-treated animals (1.5%; Fig. 6C,D). Quantifica-
tion of the firing rate (Fig. 6E) and after-discharge (Fig. 6F) of
SEA units revealed statistically significant differences between
Kv9.1 siRNA and control-treated groups (p 	 0.05). Impor-
tantly, we confirmed that a very similar phenomenon could be
observed in neuropathic animals subjected to nerve injury (Fig.
6C–F) and this was again significant compared with control an-
imals (incidence, p 	 0.001; firing rate, p 	 0.05). Interestingly,
SEA was not exclusively linked to activation of the recorded axon,
since increasing the stimulus strength to include C-fibers greatly
augmented the degree of SEA seen in A-fibers, even at low stim-
ulation frequencies (Fig. 7).
Kv9.1 downregulation is linked to
lower firing threshold at elevated extracellular potassium
To gain additional mechanistic insight on the hyperexcitability
changes after axotomy or experimental Kv9.1 knockdown, we
performed ex vivo intracellular recordings from myelinated DRG
neurons (conduction velocity range 3.5–30 m s1) isolated from
either naive, injured (3–5 d postaxotomy), or siRNA-treated an-
imals (Table 4). Consistent with our previous results, some in-
jured and Kv9.1 siRNA-treated neurons showed spontaneous
firing (data not shown). This spontaneous firing was not seen in
any of the naive or scrambled siRNA-treated cells. We then used
dorsal root stimulation to study parameters of the evoked APs (Fig.
8A, left). In agreement with previous work (Ma et al., 2003; Sapunar
et al., 2005), in injured neurons AP amplitude was smaller compared
with naive neurons (71.09  3.04 vs 80.55  3.26 mV; p 	 0.05); AP
half-width (APD50) was significantly widened (1.59  0.21 vs
0.87  0.11 ms, n  21; p 	 0.005); and maximum rising rate was
slower (176.08  22.58 vs 243.78  21.65 mV/ms, p 	 0.05); after-
hyperpolarization (AHP) amplitude was dramatically reduced
(5.42  0.69 vs 13.08  0.82 mV, p 	 0.001), despite no difference in
AHP half-width (AHPD50) between groups (5.74  0.81 vs 5.39 
1.28 mV). Comparison of AP parameters between scrambled and
Kv9.1 siRNA-treated neurons (Fig. 8B, left) revealed that AHPD50
was significantly shorter in the siRNA-treated group (4.63  0.59 vs
3.19  0.29 ms, p 	 0.05). Interestingly, AP amplitude (79.90  2.20
vs 78.01  1.90 mV), APD50 (0.84  0.07 vs 0.84  0.09 ms),
maximum rising rate (269.50  17.97 vs 258.16  18.80 mV/ms),
and AHP amplitude (12.76  0.77 vs 12.43  0.80 mV) did not
differ between groups.
Figure 5. Intrathecal Kv9.1 siRNA treatment induces pain behaviors in naive rats. A, qRT-PCR quantification of Kv9.1 mRNA in
rat PASMC cultures transfected with one of three Kv9.1 siRNA sequences or control siRNA (control, n  6; siRNA, n  3 per group;
*p 	 0.05 vs control, one-way ANOVA with Tukey’s). B, qRT-PCR showing Kv9.1 in vivo knock-down in L5 DRG, 4 d after intrathecal
delivery of siRNA #1 compared with vehicle or matched scrambled control (vehicle, n  4; scrambled, n  5; Kv9.1, n  7; *p 	
0.05, t test). C, IHC for Kv9.1 in scrambled- and siRNA-treated DRG to determine protein knockdown. Graphs illustrate quantifica-
tion of number of positive myelinated neurons and mean Kv9.1 signal intensity (scrambled, n  4; siRNA, n  6; **p 	 0.01,
***p 	 0.001, t test). D, Kv9.1 siRNA infusion inflicts a reduction in mechanical pain withdrawal thresholds (Kv9.1, n  7; control,
n  6; *p 	 0.05, **p 	 0.01, ***p 	 0.001 vs scrambled control or baseline, two-way repeated measurements ANOVA with
Tukey’s). E, There was no change in heat pain thresholds after siRNA treatment. Vertical arrows on x-axis denote siRNA injections.
All data represent mean  SEM.
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We then tested DRG excitability at progressively higher extra-
cellular potassium concentrations ([K]e), low (3 mM) or high
(6 –9 mM), to simulate the physiologically relevant K accumu-
lation upon elevated neuronal activity. Using this setup, we found
that threshold current for AP firing was lower in injured neurons
compared with naive, at both low (1.53  0.28 vs 2.69  0.46 nA;
p 	 0.05) and high [K]e (1.55  0.29 vs 2.41  0.51 nA, p 	
0.05, Kolmogorov–Smirnov Z test; Fig. 8C, left), consistent with
augmented excitability postinjury. When examining siRNA-
treated and scrambled control-treated animals, at low [K]e the
threshold current for the Kv9.1 siRNA-treated group was not
different to control (1.91  0.23 vs 1.91  0.24 nA) but, intrigu-
ingly, at high [K]e the threshold current for Kv9.1 siRNA neu-
rons was shifted toward lower values (1.44  0.21 vs 1.76  0.33
nA, p 	 0.05, Kolmogorov–Smirnov Z test; Fig. 8C, right). An-
other interesting feature of the nerve-injured and siRNA-treated
neurons was an increased occurrence of repetitive firing to cur-
rent injection in the presence of high [K]e (Fig. 8A,B, right). It
is important to note that the observed changes in current thresh-
old were not due to variations in input resistance or resting mem-
brane potential, as these parameters were not significantly
different between naive and injured or control and siRNA-
treated animals (Table 4).
Finally, to investigate whether the Kv9.1 silencing effect is
mediated through Kv2 modulation, we used the same experi-
mental setting to measure A-fiber excitability in the presence of
the Kv2 channel gating modifier stromatoxin-1, which shifts the
channel activation toward more depolarized potentials (Fig. 8D).
Interestingly, when we analyzed the same array of excitability
parameters, the only ones altered upon application of
stromatoxin-1 were threshold current (lowered from 2.87  0.38
to 2.50  0.37 nA, p 	 0.005, n  13, paired t test) and AHPD50
(reduced from 3.36  0.29 to 2.76  0.30 ms, p 	 0.05, n  13,
paired t test). All other parameters including resting membrane
potential and input resistance were not altered by stromatoxin-1,
and this effect was reversible upon drug washout (data not
Figure 6. Kv9.1 knock-down triggers ectopic activity and a form of peripheral wind-up in response to stimulation. A, Schematic illustrating the positions of stimulating and recording electrodes.
B, Example recordings from centrally disconnected L4/L5 strands demonstrating SA in Kv9.1 siRNA-treated or nerve-injured rats, but not in control (scrambled siRNA) animals. C, Frequency-
dependent SEA (denoted by double arrowheads) in Kv9.1 siRNA-treated (middle) and injured (right), but not control (left) animals. This activity is not locked in time and can be seen in between
stimulation events (vertical arrows on top of 5 Hz stimulation traces, only first 5 shown). Also note the prolonged after-discharge (AD) observed in siRNA-treated and injured animals. D, Percentage
of units showing SA and SEA in control (n  269), Kv9.1 siRNA-treated (n  369) and injured (n  176) animals (*p 	 0.05, **p 	 0.01, ***p 	 0.001 vs control,  2 test). E, Firing rate of SEA
units at different stimulation frequencies (mean  SEM; control, n  4; siRNA, n  22; injured, n  17; *p 	 0.05 vs control, two-way ANOVA with Tukey’s). F, Quantification of AD rate per SEA
unit (mean  SEM; *p 	 0.05 vs control, Mann–Whitney test).
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shown), confirming the toxin-specific effect. These alterations
closely mimic the ones observed by Kv9.1 inhibition through
siRNA treatment, thus further highlighting a mode of action that
involves Kv2 channel modulation.
In summary, our electrophysiological recordings indicate that
diminished Kv9.1 function causes lower firing thresholds and
augmented firing rates in A-fibers, leading to spontaneous and
evoked hyperexcitability, which is dependent on extracellular po-
tassium accumulation.
Discussion
There has been a lot of speculation about the molecular mechanism
underlying peripheral hyperexcitability in chronic pain states. So far,
most efforts have examined augmented sodium channel function as
a cause and, despite acquiring valuable insight (Dib-Hajj et al.,
2010), results indicate that postaxotomy changes cannot be satisfac-
torily explained by solely considering changes in sodium channel
conductance (Flake et al., 2004). These and more recent findings
(Emery et al., 2011) emphasize the notion that other ion channels are
critical codeterminants of the injury response. In line with this view,
the data presented here suggest that an important driver of increased
excitability and pathological pain is downregulation of the potas-
sium channel Kv9.1 subunit.
Development of ectopic firing following nerve lesions is one of
the hallmarks of neuropathic pain, well characterized in human
patients and animal pain models (Kajander and Bennett, 1992;
Campero et al., 1998; Han et al., 2000). This continuous barrage
of impulses provides a framework to explain spontaneous pain,
and it may also feed exaggerated responses to stimulation by
triggering central sensitization (Torebjörk et al., 1992; Ziegler et
al., 1999). The most compelling evidence supporting a role of
ectopic discharge in pain generation stems from the finding that
preventing this activity from entering the spinal cord precludes
the development of pain in animals (Sheen and Chung, 1993;
Yoon et al., 1996; Sukhotinsky et al., 2004) and humans (Camp-
bell et al., 1988; Gracely et al., 1992). The first interesting obser-
vation in our studies was that Kv9.1 is confined to a population of
myelinated DRG neurons, which mainly give rise to A- and
A-fibers. A-fibers are predominantly low-threshold mechano-
receptors, while A-fibers can directly mediate nociceptive re-
sponses (alongside a minority of A nociceptors) (Djouhri and
Lawson, 2004). A role for A-fiber conduction in human pain is
emphasized because (1) ectopic activity has most extensively
been described in A-fibers (Kajander and Bennett, 1992; Boucher
et al., 2000), (2) low-threshold stimulation of A-fibers in sensi-
tized states provokes painful sensations in humans (Campbell et
al., 1988; Torebjörk et al., 1992; Ziegler et al., 1999), and (3) nerve
lesions can trigger a “phenotypic switch” in A-fibers, which then
start producing pain-inducing molecules (Noguchi et al., 1994;
Neumann et al., 1996; Michael et al., 1999). For instance, artificial
activation of injured, but not intact, myelinated fibers can trigger
c-fos expression and ERK phosphorylation in spinal cord neu-
rons, events suggestive of central sensitization (Molander et al.,
1994; Wang et al., 2004).
A second intriguing result was that Kv9.1 expression is ro-
bustly attenuated within 24 h of axotomy, which coincides with
the development of spontaneous firing and behavioral hypersen-
sitivity in the SNT model (Liu et al., 2000). Importantly, this was
a causative effect, as experimental Kv9.1 knock-down in naive
animals led to elevated occurrence of spontaneous and stimulus-
evoked activity within A-fibers, similar in nature and magnitude
to that arising after peripheral injury. The increased A-fiber ex-
citability was also coupled to altered pain behaviors, since Kv9.1
knock-down led to a significant drop in mechanical pain thresh-
olds of naive rats, while heat pain thresholds remained un-
changed. These findings are consistent with the classical role of
A-fibers in mechanotransduction, as well as with previous results
demonstrating that animals treated with resiniferatoxin (a
C-fiber neurotoxin) develop tactile allodynia but not thermal
hyperalgesia following nerve injury (Ossipov et al., 1999).
Of particular interest, we illustrate that Kv9.1 dysfunction can
also trigger a form of stimulus-dependent hyperexcitability in
sensory neurons. This firing did not depend on any CNS connec-
tion as it was observed in axons that were centrally disconnected.
A very similar after-discharge phenomenon induced by cross-
excitation selectively in damaged A-fibers has previously been
reported (Devor and Wall, 1990). Our intracellular recordings
suggest that in both injured and siRNA-treated animals, this hy-
perexcitability is connected to lowered firing thresholds and de-
pendent on extracellular potassium ([K]e) accumulation
within the nerve following repetitive stimulation (Sykov á and
Vyklicky̆, 1977; Nicoll, 1979; Svoboda et al., 1988). Thus, Kv9.1
downregulation or injury caused a shift toward lower firing
thresholds when [K]e was 6 mM or greater (Utzschneider et al.,
1992). This peripheral wind-up phenomenon is particularly
suited to explain poorly understood symptoms that do not arise
spontaneously and are empirically linked to A-fiber function. For
instance, hyperpathia is characterized by a delayed and exagger-
ated painful reaction to repetitive, low-threshold stimulation and
a common feature in patients is that pain is explosive and outlasts
the inducing stimulus (Walters, 1959). Our data suggest that
Kv9.1 ablation can render myelinated fibers prone to depolariza-
tion via a [K]e-dependent pathway, which can also induce
spontaneous discharge. Progressive A-fiber recruitment further
elevates [K]e and initiates a chain reaction building up to a
firing crescendo, which may underlie the explosive nature of the
pain. Consistent with this notion, we found that SEA in A-fibers
was exaggerated when stimulation strength was raised to also
include C-fiber activation. Finally, the observed after-discharge
could explain the after-sensation present in patients with hyper-
pathia. A similar cross-excitation mechanism could be involved
in generation and spreading of paresthetic sensations (e.g., tin-
gling, “pins and needles”), which can sometimes acquire unpleas-
ant qualities (dysesthesias and pain).
Interestingly, Kv9.1 is not a pore-forming subunit and there-
fore its influence on sensory neuron excitability must be indirect
Figure 7. SEA in siRNA-treated animals is exaggerated by C-fiber activation. Recording from
an siRNA-treated animal strand, featuring a small unit firing spontaneously (arrowhead). After
stimulation at A-fiber strength (2 Hz), a second previously silent unit is recruited and shows
progressive SEA (top, double arrowheads). This phenomenon was exaggerated when delivering
stimuli capable of activating C-fibers, even at low frequencies (1 Hz, bottom).
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(Salinas et al., 1997). Kv9.1 can form heterotetramers with mem-
bers of the Kv2 family (Kv2.1 and Kv2.2) in vitro (Kerschen-
steiner et al., 2005) and this interaction leads to alteration of the
functional channel kinetics (Salinas et al., 1997; Stocker and Ker-
schensteiner, 1998; Kerschensteiner et al., 2005), such as modifi-
cations in current amplitude and voltage-dependency of
activation and inactivation. Interestingly, Kv9.1 modulation
could have opposing actions depending on the ion channel com-
plement of the cell; computer simulations predict that the pres-
ence of Kv9.1 can, in certain contexts, produce an inhibition of
firing during sustained depolarization (Richardson and Kacz-
marek, 2000). Our study is the first one to address the effect of
Kv9.1 in vivo and our results strongly suggest that, in sensory
neurons, Kv9.1 is an inhibitor of neuronal excitability. Although
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Figure 8. Intracellular APs from naive, injured (3–5 d postaxotomy), scrambled siRNA-treated, and Kv9.1 siRNA-treated neurons and the effect of elevated [K ]e on excitability. A, Left,
Representative APs evoked by dorsal root stimulation from a naive (gray) or an injured (black) cell. Arrow indicates the stimulus artifact. Right, Responses to a series of depolarizing current injections
from a naive and an injured neuron at 3, 6, and 9 mM [K ]e. B, Left, Representative APs from scrambled- and Kv9.1 siRNA-treated neurons. The inset highlights the shortened AHP in Kv9.1
siRNA-treated neuron on a different scale. Right, neuronal responses to a series of depolarizing current injections from control or Kv9.1 siRNA-treated neurons at 3, 6, and 9 mM [K ]e. C, Comparison
of frequency distribution of threshold current at elevated [K ]e (6 –9 mM) between naive/injured neurons (left) and scrambled/Kv9.1 siRNA-treated neurons (right). Dashed lines indicate the
respective cumulative percentages, illustrating the shift toward lower values in injured and Kv9.1 siRNA-treated neurons. D, representative AP from a naive neuron in the absence (black) or presence
(gray) of the Kv2 blocker stromatoxin-1 (ScTx). The inset highlights the shortened AHP caused by ScTx, similar to Kv9.1 siRNA treatment.
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an entirely novel interaction cannot be excluded, the ScTx exper-
iment indicates that the Kv9.1 effect on excitability is indeed
mediated via modulation of Kv2 function, since Kv2 blockade
induced very similar electrophysiological changes. Importantly,
the shortened hyperpolarization (reduced AHPD50) observed in
both ScTx and Kv9.1 siRNA-treated cells could explain the in-
crease in firing frequency observed during elevated [K]e. Inhi-
bition of Kv9.1 or Kv2 also resulted in lowered firing thresholds,
presumably through a reduction in Kv2 channel conductance,
but more work will be needed to decipher the exact molecular
mechanism of this alteration.
Another possibility is that Kv9.1 association with Kv2 mem-
bers in vivo affects channel trafficking (Pongs and Schwarz,
2010); a Kv9.1-contained signal could promote Kv2 incorpora-
tion to cell membrane or transport to the axon hillock, effectively
increasing Kv2 function. For instance, it was recently demon-
strated that phosphorylation-dependent association of Kv1 with
the auxiliary subunit Kv2 regulates targeting to the axon hillock
(Vacher et al., 2011). Interestingly, Kv2.1 clustering and function
in CNS neurons is also phosphorylation dependent and Kv9.1
can donate a number of phosphorylation sites upon association
(Salinas et al., 1997; Stocker and Kerschensteiner, 1998; Cerda
and Trimmer, 2011).
In many neurons, Kv2.1 conductance represents the majority
of delayed rectifier current (Murakoshi and Trimmer, 1999) and
Kv2.1 modulation has a very prominent role in dynamic control
of excitability (Misonou et al., 2004). We have shown here that
myelinated DRG neurons have the capacity for Kv2 and Kv9.1
interaction, since they largely coexpress these subunits. A similar
Kv2 modulation by silent subunits is present in small DRG neu-
rons, where two distinct Kv2.1 current components are detected:
one reflecting homotetrameric Kv2.1 channels and the other at-
tributed to heterotetramers of Kv2.1 with modulatory subunits
(Bocksteins et al., 2009). Here, we conclude that the Kv9.1 sub-
unit that is dramatically downregulated following peripheral
nerve injury confers plasticity of Kv2 channel conductance,
which in turn regulates the intrinsic excitability of myelinated
primary sensory neurons. Similarly, different combinations of
Kv4.3 with Kv1.4 and Kv3.4 are linked to A-current plasticity in
sensory neurons, and axotomy-induced Kv4.3 downregulation
in small DRG neurons has particular relevance to evoked neuro-
pathic pain (Chien et al., 2007). Interestingly, Kv2.1 protein has
also been reported slightly reduced (20%) in large neurons
after axotomy (Ishikawa et al., 1999) and therefore we cannot
exclude at least some involvement of Kv2.1 downregulation in
the hyperexcitable phenotype following injury.
The identification of numerous human channelopathies lead-
ing to detrimental nervous system dysfunctions, many of which
are coupled to hyperexcitability and pain, highlights the impor-
tance of ion channels for physiological function (Cregg et al.,
2010). Our results propose that Kv9.1 downregulation after nerve
injury may be the molecular switch controlling myelinated sen-
sory neuron hyperexcitability. Intriguingly, a recent wide-
genome association screen in humans identified a Kv9.1
polymorphism associated with susceptibility to develop chronic
neuropathic pain after back surgery or leg amputation (Costigan
et al., 2010), suggesting that the mechanisms described in our
studies will be of direct clinical relevance to human pain. Future
efforts to elucidate the precise pathways involved, combined with
approaches aiming to compensate loss of Kv9.1 function, may
create novel therapeutic opportunities for neuropathic pain
management.
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